
Novartis Ag (0K9E)
LSE
The current 0K9E market cap is 151.67B. The company's latest EPS is USD 6.0458 and P/E is 18.39.
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 49.9B | 52.88B | 51.83B | 54.11B | 51.72B |
Operating Income | 10.83B | 27.03B | 9.19B | 10.02B | 14.51B |
Net Income | 8.07B | 24.02B | 6.96B | 14.85B | 11.94B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 132.06B | 131.8B | 117.45B | 99.95B | 102.25B |
Total Liabilities | 75.39B | 63.97B | 58.03B | 53.2B | 58.12B |
Total Equity | 56.67B | 67.82B | 59.42B | 46.75B | 44.13B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 13.65B | 15.07B | 14.24B | 9.84B | 17.62B |
Investing | -13.18B | 4.21B | 1.47B | N/A | -7.51B |
Financing | -2.21B | -16.26B | -20.56B | N/A | -11.74B |
Market Cap | 151.67B |
Price to Earnings Ratio | 18.39 |
Price to Sales Ratio | 4.24 |
Price to Cash Ratio | 19.16 |
Price to Book Ratio | 4.98 |
Dividend Yield | - |
Shares Outstanding | 1.98B |
Average Volume (1 week) | 212 |
Average Volume (1 Month) | 1.5k |
52 Week Change | 0.00% |
52 Week High | 76.79 |
52 Week Low | 76.79 |
Spread (Intraday) | 0 (0%) |
Company Name | Novartis Ag |
Address |
po box basel 4002 |
Website | https://www.novartis.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.